Article info

Download PDFPDF

Original research
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers

Authors

  1. Correspondence to David S Hong; dshong{at}mdanderson.org
View Full Text

Citation

Hong DS, Parikh A, Shapiro GI, et al
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers

Publication history

  • Accepted March 21, 2020
  • First published June 17, 2020.
Online issue publication 
June 17, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.